Albany, NY -- (SBWIRE) -- 12/19/2018 -- The global analgesics market is expected to expand at a CAGR of 5.0% over the forecast period 2018–2028. The global analgesics market is expected to be dominated by North America with 49.0% revenue share in 2018.

Obtain a Sample copy of Latest Trends in Analgesics Market @ https://www.mrrse.com/sample/17474

Regional Outlook

Geographically, the global analgesics market is expected to be dominated by North America due to increasing burden of pain management and adoption of premium-priced opioids. The growing number of surgeries and prevalence of cancer coupled with penetration of effective pain management medications are the other factors expected to fuel the growth of the analgesics market in the region.

By country, the U.S. is expected to be the most lucrative analgesics market followed by China. According to the National Institute of Health (NIH) and Centers for Disease Control and Prevention (CDC), more than 30% of Americans are living with some form of chronic or severe pain. The reimbursement scenario for pain management medications in the U.S. is further expected to fuel the growth of the analgesics market. Higher penetration of analgesics drugs for pain management coupled with higher treatment seeking rate is expected to drive the growth of the U.S. analgesics market over the forecast period. China is expected to be second large market for analgesics due to increasing number of surgical procedures as well as prevalence of cancer and neuropathic pain. Usually, non-steroidal anti-inflammatory drugs (NSAIDs) are used in China for pain management, but from the last decade the adoption of opioids for pain management has increased at a significant rate. Besides, extended efforts are been made by various analgesics manufacturers to increase their market footprints by undergoing collaborations, partnerships, mergers and acquisitions with local analgesics drug manufacturers, e.g., Purdue Pharma L.P. and Mundipharma International extended their opioid product portfolio in China in 2014 and 2018, respectively.

In terms of revenue share, Canada, Germany and France stand at the third, fourth and fifth place, respectively, in the analgesics market. By region, Western Europe is expected to be the second large analgesics market due to high penetration of analgesics for pain management. Asia Pacific is expected to witness fastest CAGR of 8.0% (2018-2028) owing to increasing adoption of advanced pain care drugs, government initiatives to spread awareness and various welfare schemes. Less availability and affordability of high efficacy drugs, such as opioid analgesics, is expected to hamper the growth of analgesics market in Asia Pacific. The Middle East and Africa is the least lucrative analgesics market due to low adoption of pain management medications. Latin America is experiencing a steady growth, but is expected to be less lucrative analgesics market due to undertreatment of pain.

Examine Full Research Study with Complete TOC Click on Below Link- https://www.mrrse.com/global-analgesics-market

Key Insights

Favourable reimbursement scenario in North America and Western Europe for pain management, particularly for patients with cancer pain and inpatient pain, is expected to drive the growth of the analgesics market in the regions over the forecast period.
The North America analgesics market size is expected to represent a high incremental opportunity of US$ 1,476.5 in 2018 over 2017
Various non-opioid analgesics to treat moderate to chronic pain are under the development phase due to increased abusive consumption of opioid drugs for non-medical purpose
Various manufacturers are developing opioids with abuse deterrence properties to reduce the abusive consumption of opioids for non-medical purpose, which is expected to contribute to the growth of the analgesics market.
Asia Pacific is expected to the fast-growing analgesics market due to growing pain treatment seeking rate.
Various analgesics manufacturers are focusing on to expand their market footprints by undergoing collaborations, mergers & acquisitions, partnerships with local analgesics manufacturers, e.g., Grunenthal and Mundipharma have entered into a license and distribution agreement, under which Mundipharma will promote and distribute Grunenthal's tramal (tramadol) in China from May 1, 2018.
Factors and Trends Impacting the Growth of the Market

The number of cancer cases is increasing and so is the prevalence of cancer pain, which is expected to drive the demand for analgesics over the forecast period.
During 1999–2015, abusive consumption of opioid analgesics for non-medical purpose resulted in more than 183,000 deaths in the U.S.
Various opioid manufacturing companies withdrew their products and stopped the promotion of opioids, e.g. Endo International plc voluntarily stopped promoting opioid products to the U.S. healthcare professionals and eliminated the company's entire U.S. pain product sales force. Endo also voluntarily withdrew Opana ER from the analgesics market. Purdue Pharma L.P. restructured and significantly reduced their commercial operation, and announced that their sales representatives will no longer promote opioids to prescribers.
Undertreatment of cancer pain is a major challenge in the Asian countries, where the percentage of patients with negative pain management index (PMI), which represents the degree of undertreatment of pain, ranged from 27.0% to 79.0%. Whereas, the U.S. (39.1–3%) and Europe (19.1–26.6%) have lower mean negative PMI.
 For More Information to Enquiry About Report You Can Click On - https://www.mrrse.com/enquiry/17474

About MRRSE
Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE's repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact Us

State Tower
90, State Street
Suite 700             
Albany, NY – 12207(United State)
Telephone: +1-518-730-0559(USA & Canada Toll-Free)
Email: sales@mrrse.com
Website: https://www.mrrse.com/